Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$34.5 - $42.19 $290,662 - $355,450
-8,425 Reduced 10.89%
68,910 $2.9 Million
Q1 2023

May 11, 2023

BUY
$33.32 - $40.98 $2.58 Million - $3.17 Million
77,335 New
77,335 $2.76 Million
Q3 2022

Nov 10, 2022

BUY
$46.5 - $79.14 $2.28 Million - $3.88 Million
48,972 Added 112.98%
92,318 $4.35 Million
Q2 2022

Aug 19, 2022

BUY
$63.06 - $84.75 $966,962 - $1.3 Million
15,334 Added 54.74%
43,346 $3.11 Million
Q1 2022

May 13, 2022

BUY
$74.15 - $99.36 $2.08 Million - $2.78 Million
28,012 New
28,012 $2.27 Million
Q4 2021

Feb 11, 2022

SELL
$86.01 - $102.89 $1.15 Million - $1.37 Million
-13,331 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$84.7 - $96.31 $1.13 Million - $1.28 Million
13,331 New
13,331 $1.17 Million
Q1 2021

May 17, 2021

SELL
$67.36 - $80.76 $3.42 Million - $4.1 Million
-50,742 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$53.08 - $69.86 $1.46 Million - $1.92 Million
27,498 Added 118.3%
50,742 $3.46 Million
Q3 2020

Nov 16, 2020

SELL
$51.29 - $65.09 $3.1 Million - $3.93 Million
-60,344 Reduced 72.19%
23,244 $1.24 Million
Q2 2020

Aug 14, 2020

BUY
$34.32 - $62.43 $2.25 Million - $4.08 Million
65,431 Added 360.36%
83,588 $4.87 Million
Q1 2020

May 15, 2020

BUY
$32.64 - $73.63 $255,179 - $575,639
7,818 Added 75.62%
18,157 $716,000
Q4 2019

Feb 14, 2020

BUY
$48.0 - $59.55 $496,272 - $615,687
10,339 New
10,339 $615,000
Q2 2019

Aug 14, 2019

SELL
$40.81 - $52.42 $732,049 - $940,309
-17,938 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$36.91 - $55.7 $662,091 - $999,146
17,938 New
17,938 $928,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.